Planning Around Disasters and Anticipating Challenges
February 25, 2021
How Sentry maintained business continuity during the COVID-19 pandemic and beyond.
Sentry team to participate in the 2019 Susan G. Komen Race for the Cure®
April 22, 2019
This Saturday, April 27th, 2019 several Sentry BioPharma Services team members will be proudly participating in the 2019 Komen Central Indiana Race for the Cure®.
Biologics Contribute to Growth in Pharma Products Cold-Chain Market
September 12, 2018
In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022.
FDA Researchers Explore Fundamental Chemical Reaction that Could Threaten the Quality of Therapeutic Protein Products
September 11, 2018
In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur
Sentry representatives attend DCAT week
March 19, 2018
Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT)
EMA Announces Brexit Business Continuity Plan
August 3, 2017
In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business
EU Countries Contend to Be New Host Country of the European Medicines Agency
July 31, 2017
Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting.
Sentry Hosts Local Congressman Hollingsworth and BIO Health Care Representatives
July 12, 2017
Sentry BioPharma Services recently hosted a round table discussion with Congressman Trey Hollingsworth (IN 9th District) and representatives